Fufeng Group Limited logo

Fufeng Group Limited

0546.HK

HKSEBasic MaterialsChemicals - Specialty

Latest quote

HK$5.165

−HK$0.07 · -1.34%

Aug 24, 11:58 AM HKT

0546.HK company overview

Regular session · HKT · Market data may be delayed.

Company profile

Company website

Fufeng Group Limited, an investment holding company, specializes in the global production and distribution of fermentation-based food additives, biochemicals, and starch-derived products, operating across markets in the People's Republic of China and internationally. Its business is structured into several key segments: Food Additives, Animal Nutrition, High-End Amino Acid, Colloid, and an encompassing 'Other' segment. The Food Additives division is responsible for manufacturing and selling items such as monosodium glutamate (MSG), starch sweeteners, glutamic acid, compound seasonings, and corn oil. The Animal Nutrition segment focuses on producing and selling refined corn products, threonine, and lysine. High-end amino acids are offered through its dedicated segment, while the Colloid segment provides specialty gums like xanthan and gellan gum. The 'Other' segment encompasses a diverse range of products, including fertilizers, synthetic ammonia, and pharmaceuticals. Beyond these core activities, Fufeng Group is also engaged in the manufacturing and sale of construction materials such as autoclaved aerated concrete blocks and bricks, alongside eubacteria material medicine and various preparations. The company actively invests in the research, development, promotion, and industrialization of innovative biological techniques and their resultant achievements. Furthermore, it deals in cosmetics, biological products, and health foods, while also offering logistics, equity investment, and biological technique information services. Fufeng Group Limited was founded in 1999 and is headquartered in Linyi, People's Republic of China.

Industry
Chemicals - Specialty
Sector
Basic Materials
Headquarters
CN
CEO
Deheng Li
Listed since
Feb 8, 2007
Employees
17,000

Market position

Day range

Current HK$5.165

52-week range

Current HK$5.165

Open
HK$5.185
Previous close
HK$5.235
Volume
327.4K
0.07× average
Average volume
4.98M
Average daily volume
Market cap
12.95B HKD
Beta
-0.06
Market reference 1
50-day average
HK$5.0701
+1.87% above average
200-day average
HK$7.0024
-26.24% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
16.63B CNY
EV / EBITDA
4.27×
Earnings yield
13.89%
Free cash flow yield
1.36%

Profitability & efficiency

Return on equity
12.66%
Return on assets
5.64%
Return on invested capital
5.74%

Financial health

Current ratio
1.24×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends28%20%12%4%Gross margin, FY2021: 18.13%Gross margin, FY2022: 26.25%Gross margin, FY2023: 22.31%Gross margin, FY2024: 18.22%Gross margin, FY2025: 19.66%Operating margin, FY2021: 7.34%Operating margin, FY2022: 19.11%Operating margin, FY2023: 13.21%Operating margin, FY2024: 9.16%Operating margin, FY2025: 9.78%Net margin, FY2021: 5.95%Net margin, FY2022: 14.05%Net margin, FY2023: 11.23%Net margin, FY2024: 8.33%Net margin, FY2025: 8.84%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 18.13%. Gross margin FY2022 26.25%. Gross margin FY2023 22.31%. Gross margin FY2024 18.22%. Gross margin FY2025 19.66%. Operating margin FY2021 7.34%. Operating margin FY2022 19.11%. Operating margin FY2023 13.21%. Operating margin FY2024 9.16%. Operating margin FY2025 9.78%. Net margin FY2021 5.95%. Net margin FY2022 14.05%. Net margin FY2023 11.23%. Net margin FY2024 8.33%. Net margin FY2025 8.84%.

Income trends

Revenue

27.88B CNY+0.44%

Operating income

2.73B CNY+7.17%

Net income

2.47B CNY+6.61%
Income trends across reported periods30.68B CNY19.99B CNY9.3B CNY−1.39B CNYRevenue, FY2021: 21.54B CNYRevenue, FY2022: 27.47B CNYRevenue, FY2023: 28.01B CNYRevenue, FY2024: 27.76B CNYRevenue, FY2025: 27.88B CNYOperating income, FY2021: 1.58B CNYOperating income, FY2022: 5.25B CNYOperating income, FY2023: 3.7B CNYOperating income, FY2024: 2.54B CNYOperating income, FY2025: 2.73B CNYNet income, FY2021: 1.28B CNYNet income, FY2022: 3.86B CNYNet income, FY2023: 3.14B CNYNet income, FY2024: 2.31B CNYNet income, FY2025: 2.47B CNYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 21.54B CNY. Revenue FY2022 27.47B CNY. Revenue FY2023 28.01B CNY. Revenue FY2024 27.76B CNY. Revenue FY2025 27.88B CNY. Operating income FY2021 1.58B CNY. Operating income FY2022 5.25B CNY. Operating income FY2023 3.7B CNY. Operating income FY2024 2.54B CNY. Operating income FY2025 2.73B CNY. Net income FY2021 1.28B CNY. Net income FY2022 3.86B CNY. Net income FY2023 3.14B CNY. Net income FY2024 2.31B CNY. Net income FY2025 2.47B CNY.
Metric (CNY)FY2025FY2024FY2023FY2022FY2021
Revenue27.88B CNY27.76B CNY28.01B CNY27.47B CNY21.54B CNY
Cost of goods sold22.4B CNY22.7B CNY21.76B CNY20.26B CNY17.63B CNY
Gross profit5.48B CNY5.06B CNY6.25B CNY7.21B CNY3.91B CNY
Research and development370.42M CNY375.01M CNY382.08M CNY386.96M CNY
Selling, general, and administrative3.35B CNY3.05B CNY3.01B CNY2.8B CNY2.35B CNY
Operating expenses2.76B CNY2.51B CNY2.55B CNY1.96B CNY2.32B CNY
Interest income530.45M CNY498.66M CNY330.5M CNY100.77M CNY36.27M CNY
Interest expense262.08M CNY203.79M CNY165.05M CNY238.5M CNY172.71M CNY
Depreciation and amortization1.27B CNY1.1B CNY1.1B CNY1.16B CNY1.22B CNY
Operating income2.73B CNY2.54B CNY3.7B CNY5.25B CNY1.58B CNY
Net income2.47B CNY2.31B CNY3.14B CNY3.86B CNY1.28B CNY

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
0.3

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates0.990.740.50.26Q2 '22Q1 '23Q3 '23Q1 '24Q3 '24Q1 '25Q3 '25Q1 '26
Q2 2022, reported Jun 30, 2022: actual 0.936, estimate —, surprise —, Comparison unavailable. Q1 2023, reported Mar 30, 2023: actual 0.824, estimate —, surprise —, Comparison unavailable. Q3 2023, reported Aug 30, 2023: actual 0.656, estimate —, surprise —, Comparison unavailable. Q1 2024, reported Mar 27, 2024: actual 0.701, estimate —, surprise —, Comparison unavailable. Q3 2024, reported Aug 29, 2024: actual 0.444, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 25, 2025: actual 0.538, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 28, 2025: actual 0.782, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Mar 26, 2026: actual 0.3, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates40.85B31.37B21.88B12.39BQ2 '22No estimateQ1 '23MissQ3 '23No estimateQ1 '24MissQ3 '24No estimateQ1 '25No estimateQ3 '25No estimateQ1 '26No estimate
Q2 2022, reported Jun 30, 2022: actual 15.14B HKD, estimate —, surprise —, Comparison unavailable. Q1 2023, reported Mar 30, 2023: actual 16.56B HKD, estimate 38.89B HKD, surprise -57.41%, Miss. Q3 2023, reported Aug 30, 2023: actual 14.69B HKD, estimate —, surprise —, Comparison unavailable. Q1 2024, reported Mar 27, 2024: actual 15.97B HKD, estimate 34.4B HKD, surprise -53.58%, Miss. Q3 2024, reported Aug 29, 2024: actual 14.36B HKD, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 25, 2025: actual 15.31B HKD, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 28, 2025: actual 15.27B HKD, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Mar 26, 2026: actual 15.49B HKD, estimate —, surprise —, Comparison unavailable.

0546.HK peers

ETFs holding 0546.HK

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research 0546.HK

research.disclaimer